No Detail Found!

Effects of Anti-Tuberculosis Drugs on Lipid Profile in Pulmonary Tuberculosis Patients

Author(s)
Iqra Amjad Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan.
Zain Abbas Malik Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan.
Abdullah Naseer Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan.
Mubashir Raza Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan.
Aqsa Imtiaz Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan.
Hina Awais Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan.
Talha Mannan Department of Microbiology, University of Health Sciences, Lahore, Pakistan
Adeel Ahmad Department of Microbiology, University of Health Sciences, Lahore, Pakistan
Nisar Ahmed Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan.
Abstract
Objective: To determine the anti-tuberculosis drugs effect on the lipid profile parameters in pulmonary tuberculosis (TB) patients. Methods: A prospective cross-sectional study was conducted at Tehsil Headquarter Hospital, Taunsa Sharif and District Headquarter Teaching Hospital, Dera Ghazi Khan from December 2020 to May 2021. The blood samples from 84 positive pulmonary TB patients were collected in three different intervals of the study, before the start of the treatment, and after the use of first four baseline drugs isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA), and ethambutol (EMB) respectively to check out the variation in lipid profile parameters such as total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), triglyceride (TG) and very low density lipoprotein (VLDL). Results: Of 84 pulmonary TB patients, the mean age was 38.1 ± 19.8 years. There were 44 (52.4%) males and 40 (47.6%) females. The mean difference of cholesterol level significantly increases from baseline to 6th and 10th week, (p-value <0.001). Similarly, HDL (p-value <0.001) and LDL (p-value <0.001) also increases significantly from baseline to 6th week and 10th week. However, no significant difference of TG (p-value 0.908) and VLDL (p-value 0.367) was observed from baseline to 6th and 10th week. Conclusion: Patients with pulmonary TB showed low lipid profile in our cohort. This shows that pulmonary TB may be a causative agent of low lipid profile. After anti-TB therapy, cholesterol, HDL, and LDL levels seem to be increased.
Publication Details
Page(s) 78-82
DOI DOI not available
Published Journal: Journal of Dow University of Health Sciences, Volume: 16, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
total cholesterol, Tuberculosis, Triglycerides, High-density lipoprotein, Very low-density Lipoprotein., Low-density Lipoprotein
0

Citations

0

Downloads

58

Views